Search - tctmd.com

Displaying 41 - 60 of 219

Sort: Relevancy | Date

Presentation TCT 2021

My Perspectives: I

Presenter: JoAnn Lindenfeld

November 05, 2021

Presentation TCT 2021

Con: Surgery Is the Optimal Therapy TODAY!

Presenter: Michael Acker

November 05, 2021

Presentation TCT 2021

Pro: TEER Is the Optimal Therapy TODAY!

Presenter: Saibal Kar

November 05, 2021

Presentation TCT 2021

New Insights From COAPT

Presenter: Gregg Stone

November 05, 2021

Presentation TCT 2021

Emerging Data From the TVT and STS Mitral Registries

Presenter: Paul Sorajja

November 05, 2021

Presentation TCT 2021

What’s New in the 2020 Valvular Heart Disease Guidelines for Primary and Secondary MR?

Presenter: Robert Bonow

November 05, 2021

Presentation TCT 2021

TCT 103: Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip™ in Atrial Functional MR: An Analysis of the Global EXPAND Study

Presenter: Nishtha Sodhi

November 05, 2021

Presentation TCT 2021

TCT 102: Assessing the Risk of Neo-Left Ventricular Outflow Tract Obstruction in Transcatheter Mitral Valve Replacement: Are We Treating All the Patients That Can be Treated?

Presenter: Keshav Kohli

November 05, 2021

Presentation TCT 2021

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Presenter: Tobias Schmidt

November 05, 2021

Presentation TCT 2021

The Role of Heart Failure Optimization Pre- and Post-Procedure

Presenter: Sean Pinney

November 04, 2021

Presentation TCT 2021

The Slippery Slope of "Too Much RV Dysfunction for TTVR" (Lessons From Surgery)

Presenter: Paul A. Grayburn

November 04, 2021

Presentation TCT 2021

Identification and Management of Patients at High Risk for Conduction Abnormalities

Presenter: Azeem Latib

November 04, 2021

Presentation TCT 2021

Don't Trip on the Wires: Managing Pacemaker Leads During TTVR

Presenter: Neil P. Fam

November 04, 2021

Presentation TCT 2021

Transcatheter Tricuspid Valve Replacement: Overview of Current Clinical State

Presenter: Molly Szerlip

November 04, 2021

Presentation TCT 2021

CLASP

Presenter: Molly Szerlip

November 04, 2021

Presentation TCT 2021

Triluminate

Presenter: Paul Sorajja

November 04, 2021

Presentation TCT 2021

Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations

Presenter: Jason Rogers

November 04, 2021

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles J. Davidson

November 04, 2021

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles Davidson

November 04, 2021

Presentation TCT 2021

Triluminate Registry: Lessons Learned for TEER Trial Design

Presenter: Georg Nickenig

November 04, 2021

Advertisement

My Perspectives: I

Con: Surgery Is the Optimal Therapy TODAY!

Pro: TEER Is the Optimal Therapy TODAY!

New Insights From COAPT

Emerging Data From the TVT and STS Mitral Registries

What’s New in the 2020 Valvular Heart Disease Guidelines for Primary and Secondary MR?

TCT 103: Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip™ in Atrial Functional MR: An Analysis of the Global EXPAND Study

TCT 102: Assessing the Risk of Neo-Left Ventricular Outflow Tract Obstruction in Transcatheter Mitral Valve Replacement: Are We Treating All the Patients That Can be Treated?

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

The Role of Heart Failure Optimization Pre- and Post-Procedure

The Slippery Slope of "Too Much RV Dysfunction for TTVR" (Lessons From Surgery)

Identification and Management of Patients at High Risk for Conduction Abnormalities

Don't Trip on the Wires: Managing Pacemaker Leads During TTVR

Transcatheter Tricuspid Valve Replacement: Overview of Current Clinical State

CLASP

Triluminate

Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Triluminate Registry: Lessons Learned for TEER Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content